Exendin-4 is a 39-amino acid long peptide analog that shares a 53% sequence homology with human GLP-1 (Parkes, 2001)
Sermorelin, by contrast, offers a balanced, evidence-informed approach that supports the bodys natural rhythm while minimizing the metabolic risks associated with direct HGH therapy. Sermorelin relies on the intact feedback loop: The brain can still monitor and adjust growth hormone levels whereas HGH may override that, or bypass it, and may be excessive or shut pituitary function down in the process
Primary Risk Factors: Age 50+ (most common demographic for NAION) Sleep apnea (often exceeds Ozempic risk contribution) Hypertension and cardiovascular disease Diabetes mellitus (doubles baseline risk) Small or crowded optic disc anatomy Previous NAION in the opposite eye Sleep apnea deserves special attention
Helps repair the skin barrier 3
We dont know the cause yet, and in both trials, it apparently led to a few patients stopping the drug